This years event will explore the changing global market and latest innovations in device design and development for injectable drug delivery. Case studies from leading industry and regulatory experts will explore platform approaches for combination products, enhanced device design and usability considerations, change management and compatibility for novel drug products

Join World-Leading experts in drug product development and delivery for this on-site meeting in London. You’ll learn about advances in the formulation of large and small molecule drugs and explore the innovations in the delivery of complex and challenging therapeutics. Discuss the latest updates in long-acting formulations, combination products, and the technologies and processes changing drug development for the better.

Bringing together leading representatives of pharmaceutical, biotechnology and academic institutions, the 2-day conference will provide first-hand information on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY.

The growing interest in alternative routes of drug and vaccine administration has experts predicting that the market for microneedle drug delivery systems could exceed $30 billion by 2025. The industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems. Pharma Ed's Microneedle & Transdermal Drug Delivery Summit 2021 brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.

The PDA Universe of Pre-Filled Syringes and Injection Devices Conference features emerging technologies and regulatory trends that relate to all aspects of application device technology. The 2021 conference will take place online under the theme Collaboration and Simplification to Accelerate Device Development and Drug Delivery. Surrounding the main conference is a week of events filled with pre-conference workshops, the conference, and several training courses.ringes and Injection Devices Conference features emerging technologies and regulatory trends that relate to all aspects of application device technology. The 2021 Conference will take place under the theme Collaboration and Simplification to Accelerate Device Development and Drug Delivery. Surrounding the main conference is a week of events filled with pre-conference workshops, the conference, and several training courses.

SMi’s Wearable Injectors and Connected Devices conference will explore the latest digital applications for on-body devices through industry case studies and perspectives, advances in device design for large volume delivery, drug/device compatibility for wearable injectors and real world examples from industry thought leaders on a patient-centric approach. Furthermore, the key regulatory considerations and guidance of the field will be presented by regulatory, notified body and industry experts for a comprehensive outlook of this exciting and ever-growing field.

With an exclusive Meetings Programme bringing together visitors and exhibitors and over 2000 free car parking spaces at Galway Racecourse, Medical Technology Ireland includes: a free two-day conference; start-up & innovation academy; Women in MedTech forum; and 200+ international exhibitors, including the world’s leading supply chain companies.

The global wearable biosensors market is a rapidly expanding industry with increasingly growing potential for applications in healthcare and technological advances. With potential in remote patient monitoring, diagnosis and detection of disease, biosensors and wearable devices are gaining substantial interest due to their opportunities to offer continuous and reliable physiological information allowing for better support of patient needs.

Regulators in North America and Europe are requiring stricter standards for the manufacture and safety testing of combination products in both the Pharma and Med device industries. This two-day summit features expert insight into CP product development, and the complex quality, safety, and regulatory compliance issues facing the CP market. Pharma Ed's Combination Products Summit 2021 provides comprehensive coverage of current and future trends in combination products for drugs, biologics and medical devices.

Partnership Opportunities in Drug Delivery (PODD) will take place in Boston, MA, US, and virtually. Pharma, biotech and the drug delivery industries gather at PODD to assess delivery needs, latest trends and learn about a wide range of innovative drug delivery technologies. PODD provides business development opportunities through networking and a partnering tool for new, emerging and established collaborations.

This two-day conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. In addition, we will focus closely on the keys to satisfying recent revisions to several applicable USP chapters, ICH Q3E, and the recently revised standards contained in ISO 10993.

SMi's Ophthalmic Drugs conference will explore new discoveries in the treatment of ocular disease, innovations in combination technologies, and the utterly unique challenges that are faced in the treatment of one of the most complex organs in the body. This two-day agenda will offer peer-to-peer networking opportunities with leaders in the ophthalmic sphere, from Heads of Drug Development and Senior Directors of Ophthalmology, all the way to academic forerunners in the research into ocular therapy.

Overcoming challenges in formulation, device design and patient compliance are the keys to your organization's ability to leverage products in the inhalation drug delivery market. Pharma Ed's Inhalation Drug Delivery Summit brings together today's leading researchers from both industry and academia to share the latest knowledge in drug and device development, from pre-clinical R&D through phase trials.